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BP100 is a short, designer-made membrane-active peptide with multiple functionalities:
antimicrobial, cell-penetrating, and fusogenic. Consisting of five lysines and 6 hydrophobic
residues, BP100 was shown to bind to lipid bilayers as an amphipathic a-helix, but its
mechanism of action remains unclear. With these features, BP100 embodies the
characteristics of two distinctly different classes of membrane-active peptides, which have
been studied in detail and where the mechanism of action is better understood. On the one
hand, its amphiphilic helical structure is similar to the pore forming magainin family of
antimicrobial peptides, though BP100 is much too short to span the membrane. On the
other hand, its length and high charge density are reminiscent of the HIV-TAT family of cell
penetrating peptides, for which inverted micelles have been postulated as translocation
intermediates, amongst other mechanisms. Assays were performed to test the antimicrobial
and hemolytic activity, the induced leakage and fusion of lipid vesicles, and cell uptake. From
these results the functional profiles of BP100, HIV-TAT, and the magainin-like peptides
magainin 2, PGLa, MSI-103, and MAP were determined and compared. It is observed that
the activity of BP100 resembles most closely the much longer amphipathic a-helical
magainin-like peptides, with high antimicrobial activity along with considerable fusogenic
and hemolytic effects. In contrast, HIV-TAT shows almost no antimicrobial, fusogenic, or
hemolytic effects. We conclude that the amphipathic helix of BP100 has a similar membrane-
based activity as magainin-like peptides and may have a similar mechanism of action.
Keywords: short multifunctional peptide BP100, cationic amphipathic a-helix, membranolytic and cell-penetrating
mechanisms, antimicrobial activity, hemolysis, vesicle fusion, vesicle leakageINTRODUCTION
Membrane-active peptides tend to have short sequences and simple secondary structures, from
which it often appears straightforward to predict their mechanism of membrane-perturbation.
Various models for peptide-lipid interactions have been proposed that are intuitively appealing,
such as the barrel-stave pore (Mathew and Balaram, 1983), the toroidal wormhole (Ludtke et al.,gy | www.frontiersin.org April 2021 | Volume 11 | Article 6095421
Mink et al. Short Multifunctional Peptide BP1001996; Huang, 2006), the carpet mechanism (Pouny et al., 1992),
and the formation of inverted micelles (Derossi et al., 1996;
Afonin et al., 2006). It has also been suggested that the physical
process of membrane solubilization by amphiphilic peptides can
be described in terms of different routes through a complex
phase diagram (Bechinger and Salnikov, 2012). However, despite
the appeal of these generalizable pictures, unexpected structural
results can be encountered when faced with the actual properties
of a specific sequence. Here, we studied the short yet highly
helical peptide BP100, which shares some striking similarities
with two distinctly different classes of membrane-active peptides:
(i) well-structured amphiphilic helical peptides such as magainin
2 (Zasloff, 1987), and (ii) short, highly charged cell penetrating
peptides such as HIV-TAT (Vives et al., 1997; Thorén
et al., 2003).
Cationic membrane-active peptides perform numerous
important biological functions in cells. It is important to
realize that they can be classified either according to their 3D
structure or according to their functional usage, for which
overlapping profiles tend to emerge. Antimicrobial peptides
(AMPs), also known as host defense peptides, form part of the
innate immune system of most organisms (Boman, 1991;
Brogden, 2005; Peschel and Sahl, 2006). Many of them fold
into amphiphilic helices and kill bacteria by permeabilizing their
membranes (Boman, 2003; Papo and Shai, 2003; Fernandez et al.,
2009). Cell-penetrating peptides (CPPs), on the other hand, are
used to transport hydrophilic cargo into cells, preferably without
damage to the plasma membrane (Langel, 2002). Some of them
also have amphiphilic helical structures, while others tend to be
highly charged and unstructured like HIV-TAT. In fact, many
CPPs show antimicrobial activity and vice versa, depending on
which cell type and lipid composition they encounter
(Nekhotiaeva et al., 2004; Henriques et al., 2006; Strandberg
et al., 2007; Wadhwani et al., 2012a). Fusion peptides (FPs),
finally, are involved in specific processes where cellular
membranes need to merge (Blumenthal et al., 2003; Zheng et al.,
2006; White et al., 2008). Many FPs are rich in Gly and have a
rather flexible structure (Reichert et al., 2007), but they also share
many similarities with AMPs and CPPs (Wadhwani et al., 2012b).
Short peptide sequences, that are easy and cost-efficient to
synthesize, are of special interest for therapeutic and biotechnological
purposes. Much effort has been spent to systematically optimize and
miniaturize naturally occurring AMPs. One such product is the 11-
mer sequence BP100 (KKLFKKILKYL-NH2), which was developed
from hybrids of cecropin and melittin (Andreu et al., 1992;
Cavallarin et al., 1998; Ferre et al., 2006; Badosa et al., 2007; Ferre
et al., 2009). BP100 had originally been optimized as a membrane-
active AMP against plant pathogens for applications in agriculture
(Badosa et al., 2007). The peptide was also found to be highly
effective against many other bacteria, with the added medical benefit
of causing only comparatively little hemolysis. Atomic force
microscopy showed severe damage of the cell envelope of
Escherichia coli bacteria at its minimum inhibitory concentration
(MIC) of 3 µM (Alves et al., 2010). Interestingly, BP100 was also
found to be taken up into tobacco cells without causing leakage
(Eggenberger et al., 2011; Eggenberger et al., 2017). It was thus usedFrontiers in Cellular and Infection Microbiology | www.frontiersin.org 2as a cell-penetrating carrier to deliver various types of cargo into
tobacco cells (Eggenberger et al., 2011; Gao et al., 2016). Considering
this excitingmultifunctional potential of BP100 towards membranes,
in the present study we extend previous studies by (i) testing the
ability of the BP100 to enter human cell lines, to (ii) studying the
toxic side effects, and (iii) - given the significant overlap between
AMPs, CPPs and FPs - checking for its fusogenic abilities.
In view of such a wide range of biological activities, a most
intriguing question concerns the mode of action by which this
short peptide permeabilizes/permeates/penetrates lipid
membranes. Obviously, BP100 does not act as a simple
detergent, as it would otherwise be highly toxic. A recent solid-
state NMR and oriented circular dichroism (OCD) study showed
that BP100 forms an amphipathic a-helix in the presence of
micelles and lipid bilayers (Wadhwani et al., 2014). Surprisingly,
the disturbance to lipid bilayers typically caused by other helical
peptides was unusually small for BP100 (Wadhwani et al., 2014;
Misiewicz et al., 2015; Zamora-Carreras et al., 2016). A careful
analysis of its molecular orientation and dynamics in the
membrane-bound state has been performed using 2H-, 15N-
and 19F-NMR, as well as OCD spectroscopy (Wadhwani et al.,
2014; Misiewicz et al., 2015; Zamora-Carreras et al., 2016). These
studies showed that the BP100 helix is aligned almost parallel to
the membrane surface, and that this short compact structure is
highly mobile as a rigid body.
To better understand the mechanism of action of BP100, we
here compare it with two classes of membrane-active peptides
which have been extensively studied. Their mechanism of action
has been mostly elucidated.
On the one hand, BP100 forms a cationic, amphipathic a-
helix in the membrane, and is therefore similar to many well-
known AMPs and CPPs. For example, magainin 2 (MAG2) from
the frog Xenopus laevis (Zasloff, 1987) consists of 23 residues
[GIGKFLHSAKKFGKAFVGEIMNS], PGLa from the same frog
(Andreu et al., 1985) has 21 residues [GMASKAGA
IAGKIAKVALKAL-NH2], and the related designed sequence
MSI-103 (Blazyk et al., 2001) also has 21 residues [(KIAGKIA)3-
NH2]. The mode of action of these long amphiphilic peptides is
attributed to the formation of oligomeric transmembrane pores,
in which the polar residues line an aqueous channel, with or
without participation of charged lipid head groups (Matsuzaki
et al., 1995; Matsuzaki, 1998; Grau-Campistany et al., 2015;
Grau-Campistany et al., 2016).
On the other hand, the short length (11 amino acids) and high
charge density (5 charges at side chains and one N-terminal), and
the efficient cell uptake of BP100 is similar to some well-known
and effective CPPs like for example the unstructured, short,
highly cationic peptides poly-arginine, poly-lysine, or the 13
residue peptide TAT[48-60] from HIV-1 [GRKKRRQRRRPPQ]
(in this paper we will just call it TAT) (Vives et al., 1997; Thorén
et al., 2003). These densely charged peptides tend to be
unstructured, both in solution and in the presence of membranes
(Futaki et al., 2001; Eiriksdottir et al., 2010;Wadhwani et al., 2012a),
and they seem to translocate spontaneously across membranes,
driven by the transmembrane potential (Terrone et al., 2003; Zhang
et al., 2009). It has been suggested that this process may involve aApril 2021 | Volume 11 | Article 609542
Mink et al. Short Multifunctional Peptide BP100collapse of the TAT peptides into inverted micelles (Afonin et al.,
2006), a cooperative electrostatic breakthrough across the lipid
bilayer (Binder and Lindblom, 2003), or proceed via an anion-
mediated route (Sakai and Matile, 2003).
Figure 1 shows a comparison of the multifunctional BP100
with MSI-103 as a representative antimicrobial peptide on the
one hand, and with the representative cell-penetrating TAT on
the other hand. BP100 shares important characteristics with each
of these membrane-active peptides, even though the magainin
family and the TAT-type peptides are considered to represent
entirely different structural classes. All three sequences carry a
similar net charge. BP100 and MSI-103 both form amphipathic
helices. BP100 and TAT has similar lengths. The key question in
our current investigation is whether BP100 operates either like
the pore forming magainin-like AMPs or rather like the densely
charged TAT-like CPPs. Even though it is often assumed that a
functional mechanism can be inferred from the structural
properties of a membrane-bound peptide, BP100 could
arguably belong to either of the two classes – or to neither of
them. To get some better understanding of its biological actions
and to investigate which mechanistic picture is most appropriate
for BP100, we have used a range of biological assays and
biophysical techniques. Here, we compare the behavior of
BP100 with the well-known amphiphilic AMPs MAG2
(Zasloff, 1987), PGLa (Soravia et al., 1988), and MSI-103
(Maloy and Kari, 1995), with the designated helicalFrontiers in Cellular and Infection Microbiology | www.frontiersin.org 3amphiphilic CPP MAP (Steiner et al., 1991; Oehlke et al.,
1998), with the densely charged TAT (Vives et al., 1997), and
in the vesicle fusion assay also with the representative fusion
peptide FP23 from HIV (White et al., 2008), as listed in Table 1.MATERIALS AND METHODS
Materials
Peptides were synthesized using a standard Fmoc solid phase
protocol (Fields and Noble, 1990; Wadhwani et al., 2014). For
cell uptake studies, BP100 and other peptides as listed in Table 1
were fluorescence labeled with Fluka 630 red (Sigma-Aldrich,FIGURE 1 | Comparison of BP100, MSI-103, and TAT, all of which have a similar net charge. On the one hand, BP100 resembles MSI-103 in having a similar AMP
function and amphipathic a-helical structure, and on the other hand, BP100 has a similar CPP function and short sequence as TAT. However, these two types of
representative peptides – MSI-103 and TAT – differ fundamentally in size and secondary structure. We suggest that MSI-103 and TAT may nevertheless resemble
each other in terms of their similar effective length and similar charge density, when considering their respective a-helical and unstructured forms in the membrane-
bound state. Peptides are shown with helices as ribbons, side chains as stick models, with N atoms in blue. Side chain and terminal charges are indicated. TAT is
unstructured and highly flexible; only one of the possible and interchanging conformations is shown. [Helix figures were prepared using the 3D-HM web application
(Reißer et al., 2014). The structure rendering was done using UCSF Chimera (Pettersen et al., 2004)].TABLE 1 | Sequences of used peptides.
Peptide Sequence Lengtha Chargeb
BP100 KKLFKKILKYL-NH2 11 +6
MAG2 GIGKFLHSAKKFGKAFVGEIMNS 23 +3/+4
PGLa GMASKAGAIAGKIAKVALKAL-NH2 21 +5
MSI-103 (KIAGKIA)3-NH2 21 +7
MAP KLALKLALKALKAALKLA-NH2 18 +6
TAT GRKKRRQRRRPPQ 13 +8
FP23 AVGIGALFLGFLGAAGSTMGARS-NH2 23 +2April 2021 | Volume 11 | ArticlaNumber of amino acid residues.
bNet charge; depending on pH, His can be protonated or deprotonated.e 609542
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swollen in DCM, 0.5 mL of 1.5 mM activated Fluka 630 red in
DMF was added and incubated overnight, then filtered, washed
(three times in DMF and three times in MeOH), dried under
vacuum for 24 h, and cleaved. All peptides were purified with







(POPS), sphingomyelin (SM), cholesterol (CHOL), and 1,2-dioleoyl-
sn-glycero-3-phosphoethanolamine-N-(lissamine rhodamine B
sulfonyl) (Rhod-PE) were obtained from Avanti Polar Lipids
(Alabaster, AL); 1,2-dierucoyl-sn-glycero-3-phosphatidylcholine
(DErPC) and 1,2-dierucoyl-sn-glycero-3-phosphatidylglycerol
(DErPG) were purchased from NOF Corp. (Grobbendonk, Belgium).
The fluorescent probes 8-amino-naphtalene-1,3,6-trisulfonic
acid sodium salt (ANTS) and pxylenebis(pyridinium)bromide




The antimicrobial activity of BP100 was tested using a standard
MIC dilution assay, as previously described (Strandberg et al.,
2007; Wadhwani et al., 2012a). Two Gram-negative strains,
Escherichia coli (DSM 498) (K12) and Enterobacter helveticus
(DSM 18396), and one Gram-positive strain, Kocuria rhizophila
(DSM 348) were used. Bacteria were grown in Luria-Bertani
medium at 37°C and 230 rpm overnight, and diluted in 1%
trypticase soy broth (TSB). Peptide stock solutions (1024 mg/mL)
were prepared in water. Microtiter plates (96 wells of 100 ml)
were filled with 50 ml of 1% TSB, and serial 2-fold dilutions of
peptides were arranged in columns. The two final rows of each
plate remained without peptide, so that the penultimate data
point served as the positive control (no peptide) and the final one
as the negative control (not inoculated). To each well (except for
the final row of each plate), an aliquot of 50 µl of a bacterial
suspension containing 106 colony-forming units/mL was added
to obtain a final volume of 100 µL. Antibacterial activities are
expressed as the MIC and correspond to the lowest concentration
of peptide, in micromolar units, at which no bacterial growth was
detected after overnight incubation at 37°C. The tests were made
in triplicate for each peptide, and the value shown is the lowest
concentration where at least for two repetitions the growth
was inhibited.
Hemolysis Assay
The hemolytic effect of the peptides was tested on human
erythrocytes as previously described (Strandberg et al., 2007).
Citrate phosphate dextrose-stabilized blood bags with
erythrocyte suspensions were obtained from the blood bank of
the local municipal hospital (Karlsruhe, Germany). Erythrocytes
were washed twice with 9-fold excess of Tris buffer (172 mM, pH
7.6 at 0°C) followed by centrifugation at 600 g for 10 min at 4°C,Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 4and kept on ice in between. After the second wash, the
erythrocytes were transferred from the sediment to a fresh tube
with the same precooled buffer to be diluted to about 10% (v/v)
hematocrit, giving the stock cell suspension, which was kept on
ice. For each peptide, serial 2-fold dilutions in Tris buffer (pH 7.6
at 37°C)/dimethylsulfoxide (9:1 v/v) were prepared to have 6.25-
200 µM, twice the desired end concentration (an equal volume of
erythrocyte suspension will be added later to start the
incubation). The stock cell suspension was further diluted to
about 0.5% (v/v). After preincubating for 3 min, 200 mL of the
resulting erythrocyte dilution was transferred to each tube of the
corresponding peptide serial dilution, to a final concentration of
0.25% (v/v). For each dilution series, zero hemolysis was
obtained by adding the erythrocytes to Tris buffer (pH 7.6 at
37°C)/dimethylsulfoxide (9:1 v/v) and measuring the background
lysis in the absence of peptide. For 100% hemolysis, the
erythrocytes were added to 0.2% of Triton X-100 (Sigma,
Germany) in the same buffer, giving a final concentration of
0.1% Triton X-100. Incubation was performed at 37°C for
20 min with gentle shaking. The tubes were centrifuged at 20
000 g for 5 min to pellet the cells, and the absorbance at 540 nm
was recorded against water. The percentage lysis was then
calculated relative to 0% lysis with buffer and 100% lysis by
Triton X-100. The absorbance measurement was repeated three
times, and the averaged values are used.
Cell Uptake Assay
HeLa TK A549 cells (from DSMZ, Braunschweig, Germany)
were cultivated in minimal essential medium (MEM) with 10%
fetal calf serum (FCS) (PAA, Cöble, Germany), and Glutamax
(Invitrogen, Karlsruhe, Germany), without antibiotics. Cell
density after incubation over night was 30000 cells/chamber in
300 µL medium. For experiments, the medium was removed and
cells incubated with peptides at the respective concentration in
HEPES Krebs Ringer (HKR) buffer, which consists of 5 mM
HEPES, 137 mM NaCl, 2.68 mM KCl, 2.05 mM MgCl2, 1.8 mM
CaCl2, and 5.55 mM glucose, pH 7.4. After 30 min (37°C, 5%
CO2) cells were washed with HKR buffer, and the behavior of
cells at variable peptide concentration examined. A confocal
microscope type SP 5 from Leica was used for fluorescence
microscopy. The 488 nm line of an argon laser was used for
excitation of calcein and the 633 nm line of a helium-neon laser
was used for excitation of Fluka 630 red. For kinetic experiments,
cells were washed after incubation for 30 minutes and placed into
MEM medium at 37°C, and studied after 1, 2, 4, 8 and 24 h. Five
minutes before microscopy, calcein AM (Fluka, Buchs,
Switzerland) was added to a final concentration of 1 nM to
examine cell viability. To avoid artifacts, cells were not fixed.
Vesicle Fusion Assay
The extent of peptide-induced lipid vesicle fusion was measured
using a lipid mixing assay based on Förster Resonance Energy
Transfer (FRET) between NBD- and rhodamine-labeled lipids,
as previously described in detail (Reichert et al., 2007; Wadhwani
et al., 2012b). Vesicles containing both dyes at 2 mol-% each were
mixed with dye-free vesicles at a 1:10 molar ratio to give a final
lipid concentration of 100 µM in buffer with 150 mM NaCl andApril 2021 | Volume 11 | Article 609542
Mink et al. Short Multifunctional Peptide BP10010 mMHEPES at pH 7.5. The initial fluorescence (lexc = 450 nm,
lem = 530 nm) of the labeled/unlabeled vesicle suspension was
taken as 0% lipid mixing, and the extent of mixing was
determined by the fluorescence level at 30 min after addition
of the peptides (4 µM, P:L = 1:25). The maximum of 100% fusion
was defined by the level obtained upon addition of the detergent
Triton-X100 to a final concentration of 0.5 mol-%. Experiments
were performed at a temperature of 37°C.
Several representative lipid mixtures were used: POPC/POPG
(molar ratio 4:1), POPC/CHOL (7:3), POPC/POPG/CHOL
(8:2:5), POPE/POPG (7:3), and POPC/POPE/POPS/SM/CHOL
(10:5:2:2:10). The fusion activities of BP100, TAT, MAG2, PGLa,
MSI-103, and MAP were compared with that of the well-known
fusion peptide FP23 from HIV-1 (Freed et al., 1990; Reichert
et al., 2007).
Vesicle Leakage Assay
The peptide-induced lipid vesicle leakage was determined using a
fluorescence-based assay as described previously in detail (Grau-
Campistany et al., 2015). Leakage of ANTS/DPX from DMoPC/
DMoPG (1:1), POPC/POPG (1:1), DErPC/DErPG (1:1), or
POPE/POPG (1:1) vesicles was determined at a range of
peptide concentration. Vesicle solution was added to a peptide
solution in buffer at pH = 7.5, and the fluorescence signal was
followed for 10 minutes. The data was scaled to the signal after
addition of Triton-X, which gave the value for 100% leakage.
Measurements were repeated at least three times.RESULTS
Antimicrobial Activity
We here used three bacterial strains to compare the antimicrobial
activity of BP100 with those of other well-known AMPs and
CPPs. Table 2 shows that the cell penetrating peptide TAT has a
very low antimicrobial activity (MIC was at least 125 µM),
whereas MAP – which is also nominally a CPP – was even
more active than the designated AMPs. Against E. coli, BP100 is
the most active peptide, against E. helveticus and K. rhizophila
MSI-103 and MAP are slightly better than BP100. In a previous
study (Wadhwani et al., 2012a), MIC values of the same peptidesFrontiers in Cellular and Infection Microbiology | www.frontiersin.org 5were determined against two Gram-negative strains (E. coli DSM
1103 and Pseudomonas aeruginosa DSM 1117) and two Gram-
positive strains (Staphylococcus aureus DSM 1104, and
Staphylococcus epidermidis DSM 1798). These values are
included in Table 2 for comparison. Here, MSI-103 was the
most active peptide, followed by BP100 and MAP. PGLa had a
lower activity and MAG2 was even less active. TAT had
essentially no activity against the tested bacteria.
Hemolysis
BP100 had also been optimized to have low hemolytic side-
effects (Badosa et al., 2007). We thus compared the hemolysis of
BP100 with that of other AMPs and CPPs. Hemolysis was
measured at peptide concentrations up to 100 µM. These data
are summarized in Table 2, giving the concentration of each
peptide needed to induce 10% hemolysis, and complete graphs
are shown in Figure 2. BP100 has a lower activity than the other
AMPs, except for MAG2, and also lower than the nominal CPP
MAP. The highly charged CPP TAT, on the other hand, has
hardly any hemolytic activity. In this assay, BP100 resembles the
long pore forming amphipathic helical peptides, especially when
the data are re-scaled according to the different weights of
peptides rather than to their molar concentrations.
Cell Uptake
A cell uptake assay was performed in human HeLa cells, and the
uptake of BP100 was compared with that of the other AMPs and
CPPs. Cell uptake was studied by fluorescence microscopy, using
peptides labeled at the N-terminus with Fluka 630 Red. In
Figure 3, the results are shown for cells incubated with BP100
at concentrations of 0.5, 1, 2 or 4 µM. Cells were also incubated
with calcein AM, which is taken up by healthy living cells and
cleaved by esterases to give a green fluorescent signal in contact
with intracellular calcium. When the peptide and calcein signals
overlap, a yellow signal appears. In Figure 3, the signals from the
separate channels are shown together with the superimposed
signals from both channels. The punctuate patterns of the
peptides inside cells thus suggest that BP100 is taken up by
endocytosis, with a good uptake at 2 µM. However, at 4 µM
BP100 begins to show considerable toxicity against HeLa cells as
seen by an increased number of rounded cells.TABLE 2 | Minimum inhibitory concentration of the investigated peptides against tested bacteria, hemolytic activity, and toxicity against HeLa cells (all values in mM).
Peptide MICa MICb HC10
c HeLa cellsd
E. coli (DSM 498) E. helveticus K. rhizophila E. coli (DSM 1103) P. aeruginosa S. aureus S. epidermidis
BP100 6.3 6.3 3.2 10 20 5 5 45 4
MAG2 75 12.5 12.5 99 >99e 99 99 >100 20
PGLa 25 16.3 4.1 30 119 15 7 16 10
MSI-103 12.5 1.6 0.8 3 28 3 2 9 4
MAP 25 3.2 0.4 31 >122e 8 4 2 2
TAT >500e 500 125 >128e 128 128 >128e >>100 > 20eApril 2021 | Volume 11 | AaNew results from this study.
bMIC values from (Wadhwani et al., 2012a).
cConcentration that induced 10% hemolysis.
dLowest tested concentration where dead HeLa cells were observed.
eNo effect was found for the highest tested concentration.rticle 609542
Mink et al. Short Multifunctional Peptide BP100The natural AMPs MAG2 (see Supporting Figure S1) and
PGLa (Figure S2) showed less uptake into HeLa cells than
BP100, yet they also entered by endocytosis (i.e. they did not
truly penetrate across the plasma membrane). These peptides
were less toxic, with dead cells found at 20 µM for MAG2, and 10
µM for PGLa. The designer-made AMP MSI-103 (Figure S3)Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 6showed endocytotic cell uptake with a similar efficiency as PGLa
and MAG2, but its cytotoxic concentration was similar to BP100.
The designer-made CPP MAP (Figure S4) was highly toxic
already at 2 µM, and therefore cell uptake at higher
concentrations could not be investigated. On the other hand,
TAT (Figure S5) showed excellent cell uptake, with no sign ofFIGURE 2 | Hemolysis of the different peptides. BP100 has a low hemolytic activity. The longer a-helical peptides have very different effects, from low for MAG2 to
very high for MAP, whereas TAT gives hardly any hemolysis in the tested concentration range.FIGURE 3 | Cell uptake of BP100 in HeLa cells. The top row shows the signal of the peptide labeled with Fluka 630 red (displayed as red channel in the merged
images at the bottom). The middle row shows the signal from calcein AM, which emits a green fluorescence when taken up by living cells (displayed as green
channel in the merged images). The bottom row shows the superposition of the two channels: Overlapping red and green signals give a yellow color where BP100
has entered a living cell, while red images show cells that are permeabilized and dead. For each column the concentration of BP100 is given in the top row. Scale
bar 25 µm.April 2021 | Volume 11 | Article 609542
Mink et al. Short Multifunctional Peptide BP100toxicity even at 20 µM. Also in this case a punctuate pattern
indicates uptake by endocytosis. The unstructured TAT peptide
is indeed a widely used CPP, and it enters the cells in a more
efficient manner than the amphipathic helical peptides, which
also seem to be more toxic. In this CPP assay, the behavior of
BP100 clearly resembles that of the magainin family of pore
forming peptides more than that of TAT.
Useful CPPs should have a negligible toxic effect, so the toxicity
of the tested peptides is compared in Table 2. In HeLa cells, the
numerical toxic value was taken as the lowest concentration where
dead cells were observed. In erythrocytes, we defined the toxic
threshold as the peptide concentration that gave 10% hemolysis.
The lowest overall toxicity was found for the highly charged TAT
peptide, followed by MAG2 and PGLa. BP100 was not very toxic
against erythrocytes, but turned out to be one of the most toxic
peptides against HeLa cells. It can be noted that the most
toxic peptides against both HeLa cells and erythrocytes were
MAP and MSI-103, two designer-made sequences. Again, we
find considerable similarity between the short BP100 and the
longer helical peptides, but little resemblance to TAT.
Vesicle Fusion Activity
Typical so-called fusion peptides, e.g. from viruses, can induce
fusion of membranes, and even some AMPs and CPPs are able to
do so. To compare the fusogenic activity of BP100 and the other
peptides, we carried out a standard fluorescence lipid mixing
assay (Wadhwani et al., 2012b) for several representative lipid
compositions. The extent of peptide-induced fusion was
examined in small unilamellar vesicles consisting of POPC/
POPG (molar ratio 4:1), POPC/CHOL (7:3), POPC/POPG/
CHOL (8:2:5), POPE/POPG (7:3), and POPC/POPE/POPS/
SM/CHOL (10:5:2:2:10). The latter composition is also calledFrontiers in Cellular and Infection Microbiology | www.frontiersin.org 7“LM3” and is often used as a model membrane in viral fusion
assays, mimicking the lipid head groups and cholesterol content
of a typical eukaryotic cell (Aloia et al., 1993; Yang et al., 2003).
The fusion activity of the tested peptides was compared with that
of the well-known fusion peptide FP23 from HIV-1. The results
are shown in Figure 4. In all vesicles containing anionic lipids,
BP100 (charge: +6) induced more fusion than FP23 (charge: +2),
indicating that BP100 is a highly effective fusogenic agent. This
finding suggests that initial electrostatic attraction is important
for membrane fusion. In uncharged vesicles of POPC/CHOL, on
the other hand, BP100 gives less fusion than FP23, in line with
poor binding of the more water-soluble BP100. The highly
charged TAT (+8) gives essentially no fusion in any lipid
system. Interestingly, the two natural AMPs from frog skin,
MAG2 and PGLa, have very low fusion activities in all tested
lipid systems. On the other hand, the two related magainin-
derived designer-helices MSI-103 and MAP give strong fusion,
comparable to BP100.
Vesicle Leakage Activity
The ability of BP100 and the other peptides to induce leakage in
POPC/POPG (1:1) vesicles was studied as a function of peptide
concentration using a fluorescence assay. The results in Table 3
show that the peptides exhibit very different activities. TAT
induces basically no leakage, even at a very high P/L of 1:12.5.
BP100 gives less leakage than the longer helical peptides. For
example, at 1:50 where the latter peptides give almost 100%
leakage, BP100 gives only 26%. Of the longer helical peptides,
MSI-103 is the least active and MAP the most active; PGLa and
MAG2 show similar activity.
An earlier leakage study had been carried out systematically
on a series of so-called KIA peptides, which are composed of theFIGURE 4 | Extent of lipid vesicle fusion induced by BP100, HIV-TAT, and the long amphiphilic helical peptides PGLa, MAG2, MSI-103 and MAP; the fusion peptide
FP23 from HIV-1 is used as a control. Vesicles with the following lipid compositions were used: POPC/POPG (molar ratio 4:1), POPC/CHOL (7:3), POPC/POPG/
CHOL (8:2:5), POPE/POPG (7:3), and POPC/POPE/POPS/SM/CHOL (10:5:2:2:10) which is called LM3. The P/L molar ratio was 1:25. Peptide-induced fusion was
measured by a lipid mixing assay based on Förster resonance energy transfer (FRET) between NBD-PE and Rh-PE as described in the Methods section.April 2021 | Volume 11 | Article 609542
Mink et al. Short Multifunctional Peptide BP100same repetitive KIAGKIA-motif as MSI-103 but differ
incrementally in length. This study had demonstrated that
peptide-induced vesicle leakage was critically dependent on
hydrophobic matching, i.e. on the relative length of the helix
compared to the thickness of the lipid bilayer (Grau-Campistany
et al., 2015). Therefore, we performed some further leakage
experiments here on BP100 and MSI-103 in several other lipid
systems with different bilayer thickness (see Supporting
Information Table S1). In thin membranes of DMoPC/
DMoPG (1:1) both peptides gave 100% leakage even at 1:100,
and in thick membranes of DErPC/DErPG (1:1) both peptides
gave essentially no leakage. In POPE/POPG (1:1), both peptides
gave lower leakage than in POPC/POPG (1:1).DISCUSSION
In this study, we have used biological and biophysical assays to
compare the membrane active peptide BP100 with several AMPs
and CPPs, that are generally considered to represent distinctly
different mechanisms of action. Our goal is to better understand
the versatile mode of action of BP100, a very short
multifunctional peptide.
We thus present a comparison of BP100 with PGLa, MAG2,
MSI-103, MAP and TAT. As shown by CD previously, BP100
folds into a compact amphiphilic a-helix with relatively high
helix content when bound to a lipid membrane (Wadhwani et al.,
2014; Zamora-Carreras et al., 2016), and the binding is
predominantly electrostatic. It is also known from earlier CD
analyses that PGLa (Matsuzaki et al., 1998; Glaser et al., 2004),
MAG2 (Matsuzaki et al., 1998), MSI-103 (Blazyk et al., 2001;
Strandberg et al., 2008) and MAP (Wadhwani et al., 2008) form
amphiphilic a-helices in a lipid environment. However, these
latter membranolytic peptides with 18-23 amino acids are long
enough to span a typical membrane in a transmembrane
orientation. BP100, composed of only 11 amino acids, is too
short to span the membrane, and yet it shows pronounced
antimicrobial activity. TAT, on the other hand, is just as short
as BP100 and carries even more charges. But in contrast to
BP100, TAT shows a random coil CD spectrum both in aqueousFrontiers in Cellular and Infection Microbiology | www.frontiersin.org 8solution (Futaki et al., 2001) and in the presence of lipid vesicles
(Wadhwani et al., 2012a).
An overview of the different peptides and their activities is
shown in Figure 5. The question is now whether (i) BP100
behaves similar to the long a-helical peptides, or whether (ii) it
rather resembles the short, highly charged TAT, or whether (iii)
it shows an altogether different behavior? It has been clearly
demonstrated that the longer peptides can assemble into
oligomeric transmembrane pores of the toroidal wormhole
type (Zerweck et al., 2017; Strandberg et al., 2020b). The most
critical requirement for pore formation in different types of
membranes is that the helix must have a sufficient length to
span the thickness of the relevant lipid bilayer under
investigation (Grau-Campistany et al., 2015; Grau-Campistany
et al., 2016). This concept of hydrophobic matching, combined
with the architecture of an oligomeric peptide pore lined with
some lipid head groups, can explain their mechanism of action
very well. However, this mode of action is not possible for the
BP100 peptide, because it is far too short. It thus seems more
likely that the compact BP100 helix disturbs the membrane in
other ways and makes it more permeable, for example by the
“carpet mechanism” (Oren and Shai, 1998). From the lipid
mixing assay, we note that BP100 is highly fusogenic,
presumably by temporarily exposing hydrophobic lipid
segments upon binding, which may also contribute to its
mechanism of action.
The biological activity of the different peptides has been
thoroughly studied, both here and in the literature. But it is
hard to compare data from different studies; to compare the
biological activity the peptides should be tested under identical
conditions using the same bacteria, same batch of blood, same
preparation of vesicles etc. Therefore, we here present new
experiments on the full series of peptides. Here, we found that
BP100 is the most active antimicrobial peptide against the tested
bacteria, together with MSI-103. MAP is also very active, while
PGLa and MAG2 show intermediate, and TAT almost no
antimicrobial effect (Table 2). These results are compatible
with a previous study of these and other peptides in other
bacteria (Wadhwani et al., 2012a), where the order of activity
was found to be MSI-103 > BP100 > MAP > PGLa > MAG2 >>
TAT. Thus, with respect to antimicrobial activity, BP100 has
more in common with the longer a-helical AMPs, and does not
behave like TAT. We can note that BP100 shows a very similar
MIC towards the tested Gram-positive and Gram-negative
bacteria, an observation that has also been previously reported
for its alanine mutants (Zamora-Carreras et al., 2016). This
behavior is in contrast with the other AMPs and MAP, which
are 6-60 times less active against Gram-negative E. coli than
against Gram-positive K. rhizophila (Table 2).
With regard to hemolysis, BP100 has a significantly lower
hemolytic activity than the longer a-helical peptides MAP, PGLa
and MSI-103, but still higher than MAG2, whereas TAT shows
almost no activity (Figure 2). These results fits with a previous
study, where hemolytic activity was also reported in the order
MAP >>MSI-103 ≈ PGLa (Strandberg et al., 2007). TAT previously
did not show any hemolytic activity (Sabatier et al., 1991;TABLE 3 | Vesicle leakage (in %) induced by the tested peptides in POPC/
POPG (1:1) vesicles at different P/L values.
Peptide P/L
1:400 1:200 1:100 1:50 1:25 1:12.5
BP100 - b 9 ± 3 15 ± 4 26 ± 3 51 ± 3 100
MAG2 27 ± 9 83 ± 11 96 ± 5 100 100c 100c
PGLa 24 ± 2 80 ± 3 100 100 100c 100c
MSI-103 - b 16 ± 4 52 ± 8 83 ± 3 100 100c
MAP 52 ± 1 100 100 100 100c 100c
TAT - b - b - b 4 6 ± 3 5aRounded to whole numbers. When all repetitions gave the same value, the standard
deviation is zero and is not given.
bNot measured.
cAssumed to be 100% since this was found at a lower concentration.
The mean value and standard deviation from 3-5 measurements are given.April 2021 | Volume 11 | Article 609542
Mink et al. Short Multifunctional Peptide BP100Wang et al., 2010). Considering that Table 2 (and Figure 2)
gives the percent of hemolysis as a function of concentration
in µM, it can be noted that BP100 contains only half as many
amino acids as PGLa and MSI-103. Therefore, by rescaling
these data to the same mass of peptide (to have a comparable
membrane surface coverage for all peptides) we would get rather
similar activities for BP100, PGLa and MSI-103 (Table 2,
given that the hemolysis increases approximately linearly with
concentration). It is apparent that the different a-helical
amphipathic peptides do not induce the same degree of
hemolysis, as MAP is much more active than PGLa and MAG2
much less, in spite of their similar length and secondary structure.
On the other hand, it is very clear that TAT has almost no
hemolytic effect. Therefore, BP100 certainly does not behave like
TAT regarding hemolysis.
Another kind of action of membrane-bound peptides is to
facilitate fusion between membranes of vesicles or cells. We find
here that BP100 has strong fusogenic activity (Figure 4), even
higher than the dedicated fusion peptide, FP23 from HIV-1,
except in uncharged POPC/CHOL. TAT shows very little fusion
in all tested lipid systems. PGLa and MAG2 also showed a very
small fusogenic effect, while MAP and especially MSI-103 had a
pronounced effect, considerably stronger than FP23. These
fusion results fit well with a previous comparison of different
AMPs and CPPs (Wadhwani et al., 2012b). Obviously, the
fusogenic effect is very different even between amphipathic a-
helical peptides of similar length. It can be noted, however, that
fusion is generally very strong for the designed peptides (MAP,
MSI-103, BP100) which were optimized for other activities (high
antimicrobial and low hemolytic activity). In contrast, the
natural AMPs (PGLa and MAG2) seem to have been
optimized by evolution to avoid any such kinds of side-effects.Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 9TAT had not yet been tested in the previous study (Wadhwani
et al., 2012b), but a mutant called TATP59W (sequence Ac-
GRKKRRQRRRPWQ-NH2) was used in another report, and a
high extent of lipid mixing was found (Thorén et al., 2005).
Fusion results from different studies are ambiguous to compare
quantitatively, because experiments were not done in an identical
way and vesicles of different lipid compositions were used. Yet,
we can note that BP100 and the longer helical AMPs have a
distinct fusogenic activity, whereas TAT is inactive.
Vesicle leakage was measured here for BP100 in the same
lipid vesicle systems as previously used for MSI-103 and related
peptides (Grau-Campistany et al., 2015; Gagnon et al., 2017).
BP100 showed less leakage in POPC/POPG (1:1) vesicles than
the longer a-helical peptides (Table 3), at the same peptide-to-
lipid molar ratio. Recalculated as mass ratios, the difference is
smaller. The leakage of BP100 is most similar to that of MSI-103.
At a high P/L of 1:12.5, also BP100 gives full leakage. In contrast,
TAT gave essentially no leakage at all, even at a very high peptide
concentration. Also in this respect, BP100 behaves more like the
other long helical peptides than like TAT.
For the KIA series of peptides a threshold length for leakage
was found, corresponding to the hydrophobic thickness of the
membrane. For thin membranes of DMoPC/DMoPG, KIA
peptides with 14 amino acids gave leakage, in medium POPC/
POPG 17 amino acids were needed, and in thick DErPC/DErPG
vesicles, the shortest peptide giving leakage had 24 amino acids.
The length of a-helices with these number of residues fit very
well with the corresponding hydrophobic thickness of the
membranes (Grau-Campistany et al., 2015). Interestingly, we
found here that BP100 – even though it is nominally too short
with an estimated length of 16.5 Å – induced full leakage in
DMoPC/DMoPG (with a hydrophobic thickness (dH) of 19.2 Å,FIGURE 5 | Overview of all available results on the different membrane-active peptides. Short peptides contain only 11-14 amino acids, while the long ones consist
of 18-23 amino acids. The newly measured activities are shown in red; previously reported lipid clustering is indicated in green [from ref. (Wadhwani et al., 2012a)];
and in blue we state whether any structural changes are known to take place as a function of peptide concentration or lipid composition, according to previous NMR
and OCD analyses. The effects are coded as: (-) negligible effect, (+) low effect, (++) medium effect, (+++) strong effect, (N/A) no data available.April 2021 | Volume 11 | Article 609542
Mink et al. Short Multifunctional Peptide BP100(Marsh, 2008)) and POPC/POPG (dH = 27-28 Å, (Kucerka et al.,
2006; Pan et al., 2012)) at P/L=1:12.5, but no leakage in DErPC/
DErPG (dH = 34.4 Å, (Kucerka et al., 2006)). Obviously, it seems
to be easier to induce leakage through a thinner membrane,
irrespective of the type of mechanism, whether pore formation or
any other kind of action. Comparing the activity of BP100 with
that of KIA peptides, BP100 falls in between KIA15 and KIA17
(Grau-Campistany et al., 2015). This comparison shows that
BP100 induces more leakage than would be expected for its
length of 11 amino acids, provided that BP100 was to operate by
the same mechanism of action as the KIA peptides.
BP100 is also a remarkable CPP that has been previously
shown to be taken up in tobacco cells (Eggenberger et al., 2011;
Gao et al., 2016; Eggenberger et al., 2017). Here, we observed also
some good uptake into HeLa cells, most likely via endocytosis.
However, already at 4 µM BP100 was toxic and caused cell death
(Figure 3). This finding clearly indicates that BP100 is unsuitable
as a CPP for these HeLa cells, in contrast to its successful CPP
applications in tobacco cells (Eggenberger et al., 2011; Gao et al.,
2016; Eggenberger et al., 2017). The longer a-helical peptides
showed varying effects. PGLa and MAG2 elicited a lower degree
of presumably endocytotic uptake, accompanied also by less
toxicity (Figures S1 and S2). MSI-103 showed good endocytotic
uptake but was toxic already at 4 µM (Figure S3), while MAP was
toxic already at 2 µM with no uptake at any lower concentrations
(Figure S4). We can thus note here (as for fusion) that all designed
a-helical peptides (BP100, MSI-103, MAP) caused significant
toxic side-effects, while the natural peptides (PGLa and MAG2)
were less toxic. TAT belongs to yet another category, showing
excellent uptake, probably via endocytosis, and no toxicity (Figure
S5). We can thus conclude that BP100 does not behave like TAT
regarding cell uptake and toxicity. The results are in line with a
previous study, where the uptake of MAG2 and TAT[47-57] in
HeLa cells showed that MAG2 was taken up more efficiently, yet
with higher toxicity, which was attributed to membrane pore
formation (Takeshima et al., 2003).
In an earlier study of lipid clustering induced by various
representative membrane-active peptides (Wadhwani et al.,
2012a), it was shown that BP100, MAG2 and TAT had a low
lipid clustering effect, while PGLa, MSI-103 and MAP showed a
high ability to segregate anionic lipids. The low activity of MAG2
can be readily attributed to its low charge. However, despite the
high number of charges on BP100 and TAT, it seems that their
short length and high dynamics make it difficult for these two
peptides to cluster anionic lipids. This scenario is one case where
BP100 actually behaves similarly to TAT.
BP100 is known to form an amphiphilic a-helix when bound
to a membrane, just like the longer peptides compared here.
However, our earlier solid-state NMR and oriented CD studies
showed a fundamentally different type of behavior for BP100
than for the other, longer amphipathic a-helices. When using
OCD to examine the re-alignment of the membrane-bound
helices as a function of peptide concentration, we found that
PGLa, MSI-103 and MAP are oriented flat on the membrane
surface. This is the preferred state at low concentration in DMPC
bilayers, but above a certain threshold concentration, P/L*, theFrontiers in Cellular and Infection Microbiology | www.frontiersin.org 10helices flip into a tilted state, which allows them to insert partly
into the membrane at an oblique angle (Bürck et al., 2008). P/L*
varies from 1:236 for MSI-103 (the most antimicrobially active of
the peptides) to 1:85 for PGLa (Bürck et al., 2008). A similar
behavior had been reported for MAG2 (Ludtke et al., 1994). The
importance of P/L* for the mechanism of action of AMPs has
been a matter of debate in the literature (Ferre et al., 2009; Melo
et al., 2009). Solid-state 15N-, 19F- and 2H-NMR revealed further
structural details of the helix re-orientation in membranes for
PGLa (Glaser et al., 2005; Strandberg et al., 2006; Tremouilhac
et al., 2006), MAP (Wadhwani et al., 2008), MSI-103 (Strandberg
et al., 2008; Strandberg et al., 2012; Strandberg et al., 2020b), and
KIA peptides (Grau-Campistany et al., 2016). These peptides all
change their orientation as a function of peptide concentration
and membrane composition.
In contrast to these long helices undergoing a distinct re-
orientation, BP100 did not show any change in alignment for P/L
ratios between 1:3000 and 1:10 in our earlier 19F-NMR analysis
(Wadhwani et al., 2014). In this respect, BP100 is more similar to
MAG2, which also does not change its orientation much as a
function of peptide concentration and membrane composition
(Strandberg et al., 2016). A possible reason for the difference
between MAG2 and for example PGLa and MSI-103 is that
MAG2 has a charged C-terminus, whereas PGLa and MSI-103
are amidated at the C-terminus, and it was shown for KIA
peptides that a charge at the C-terminus makes it much harder
for a peptide to insert into the membrane and induce leakage
(Strandberg et al., 2020a). BP100 is also amidated on the C-
terminus so there must be some other reason for its lower
propensity to change its orientation. A concentration
dependent flip of the helix tilt angle is very likely a sign of
dimerization or assembly into higher oligomers. This seems to be
an important step in the pore forming mechanism of the longer
a-helical peptides, but not in the case of BP100.
OCD and solid-state NMR data are easy to analyze for a-
helical peptides, but unfortunately these experiments are not
meaningful for unstructured arginine-rich peptides like TAT.
Given that the interaction of these charged side chains with the
phosphate head groups of the lipids is well documented (Frigyes
et al., 2001), the TAT-like peptides are expected to remain bound
to the membrane surface, below the threshold concentration at
which they can transverse the bilayer.
We have previously demonstrated that the lipid composition
can have a dramatic effect on the membrane alignment of MSI-
103 and PGLa (Strandberg et al., 2012; Strandberg et al., 2013).
For BP100, solid-state NMR showed no clear difference between
different lipid systems. Only in the presence of lyso-lipids a
slightly more tilted orientation was found for BP100 and also for
other peptides (Wadhwani et al., 2014; Misiewicz et al., 2015;
Zamora-Carreras et al., 2016). Thus, it seems that the orientation
of the short and compact BP100 helix is far less influenced by the
membrane properties than the orientation of the longer a-helical
AMPs. The helix axis of BP100 is essentially always found to be
flat on the bilayer as a time-average, but NMR showed that
BP100 executes some highly dynamic rigid-body wobbling in
liquid crystalline membranes.April 2021 | Volume 11 | Article 609542
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amphiphilic a-helical BP100 does not behave in the same way
as the longer a-helical peptides in membranes. In particular, it
does not show any signs of self-assembly and exhibits only a very
weak lipid dependence. Instead, it always remains bound to the
membrane surface as highly mobile monomers, according to
solid-state NMR and OCD. On the other hand, our present
biological assays show a functional behavior for BP100 that is
very similar to the long amphiphilic a-helices of MSI-103 and
MAP, all of which are designer-made. Compared to the natural
antimicrobial peptides PGLa and MAG2, BP100 has a higher
antimicrobial activity, but also higher side-effects like fusion
and toxicity.
Considering the short arginine-rich peptide TAT, it resembles
the short lysine-rich BP100 only in its inability to cluster anionic
lipids. In all other aspects, BP100 showed very different biological
activities, probably due to the pronounced amphipathic
character of the BP100 a-helix, which must be responsible for
the observed range of quite aggressive membrane activities. Even
if both BP100 and TAT are small and dynamic, BP100 forms a
rigid helix, in contrast to TAT, which remains flexible and may
therefore not disturb the bilayer as much as BP100.CONCLUSIONS
Magainin-type peptides, which are 18-23 amino acids long and
form amphipathic a-helices in the presence of membranes, have
strong membrane-perturbing activities. They form pores in
membranes and can kill bacteria, induce hemolysis, fusion and
leakage of vesicles, and they can even enter cells, though with
considerable toxicity due to membrane damage. TAT, on the
other hand, which consists of 13 amino acids and is largely
unstructured, can enter the cytosol efficiently and has no
significant membranolytic effects, i.e., it does not kill bacteria
or induce hemolysis as seen in several assays used here. BP100,
the interesting hybrid under investigation here, is short with high
charge density (like TAT), but folds into an amphipathic a-helix
(like the magainin-type peptides). We clearly found that BP100,
consisting of only 11 amino acids, behaves rather similarly to the
long helical peptides, but very much unlike TAT. This indicate
that the mechanism of action of BP100 is rather similar to that of
the longer helical peptides. Whereas TAT can cross the
membrane without damage, the mode of action of BP100 is to
destroy the membrane, leading to leakage, hemolysis and
antimicrobial activity. We think the most important factor is
that BP100, and the other helical peptides, can form amphipathic
structures which binds and disturbs the membrane and leads to
permeabilization. This does not prove that BP100 forms pores,
and considering its short length it should not be able to span the
membrane in a transmembrane pore, but it could still do
membrane damage by other mechanisms.
Overall, the spectrum of biological activities of BP100
resembles most closely that of the designer-made peptides
MSI-103 and MAP (21 and 18 amino acids, respectively).Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 11PGLa and MAG2 (21 and 23 amino acids, respectively) show
much less vesicle fusion, and MAG2 is hardly hemolytic,
meaning that the two natural peptides are highly active only
against bacterial membranes. We suggest that the high specificity
of PGLa and MAG2 is the result of a thorough optimization
process by evolution, whereas MSI-103, MAP and BP100 are
designer-made peptides. Even though they have been optimized
by systematic rounds of screening for high antimicrobial activity
and low hemolysis, they still show some cytotoxicity and other
side-effects such as membrane fusion. For practical applications
as an antimicrobial agent or cell-penetrating peptide in medical
use it would thus be needed to further optimize BP100 and/or
suitable galenic concepts to minimize the toxic side effects.DATA AVAILABILITY STATEMENT
The original contributions presented in the study are included in
the article/Supplementary Material. Further inquiries can be
directed to the corresponding author.AUTHOR CONTRIBUTIONS
PW and AU designed the study. CM, PW, ES, MM, JR, IW and
MC performed experiments and analyzed data. ES and AU wrote
the manuscript. All authors contributed to the article and
approved the submitted version.FUNDING
This work was supported financially by the BIF-TM program of
the Helmholtz-Gemeinschaft; by the DFG grant INST 121384/
58-1 FUGG; and by the DAAD “Portugal - Acções Integradas
Luso-Alemãs/DAAD-GRIC” grant D/07/13644.ACKNOWLEDGMENTS
We thank Andrea Eisele and Kerstin Scheubeck for help with
peptide synthesis, and Carolin Bartels for help with cell cultures.
We thank David Benz for help with leakage measurements. We
thank Dr. Jochen Bürck for critically reading the manuscript.SUPPLEMENTARY MATERIAL
The Supplementary Material for this article can be found online at:
https://www.frontiersin.org/articles/10.3389/fcimb.2021.609542/
full#supplementary-materialApril 2021 | Volume 11 | Article 609542
Mink et al. Short Multifunctional Peptide BP100REFERENCES
Afonin, S., Frey, A., Bayerl, S., Fischer, D., Wadhwani, P., Weinkauf, S., et al.
(2006). The Cell-Penetrating Peptide TAT(48-60) Induces a Non-Lamellar
Phase in DMPC Membranes. ChemPhysChem 7, 2134–2142. doi: 10.1002/
cphc.200600306
Aloia, R. C., Tian, H., and Jensen, F. C. (1993). Lipid Composition and Fluidity of the
Human Immunodeficiency Virus Envelope and Host Cell Plasma Membranes.
Proc. Natl. Acad. Sci. U.S.A. 90, 5181–5185. doi: 10.1073/pnas.90.11.5181
Alves, C. S., Melo, M. N., Franquelim, H. G., Ferre, R., Planas, M., Feliu, L., et al.
(2010). Escherichia Coli Cell Surface Perturbation and Disruption Induced by
Antimicrobial Peptides BP100 and pepR. J. Biol. Chem. 285, 27536–27544.
doi: 10.1074/jbc.M110.130955
Andreu, D., Aschauer, H., Kreil, G., and Merrifield, R. B. (1985). Solid-Phase
Synthesis of Pyla and Isolation of Its Natural Counterpart, Pgla [Pyla-(4-24)]
From Skin Secretion of Xenopus Laevis. Eur. J. Biochem. 149, 531–535.
doi: 10.1111/j.1432-1033.1985.tb08957.x
Andreu, D., Ubach, J., Boman, A., Wahlin, B., Wade, D., Merrifield, R. B., et al.
(1992). Shortened Cecropin a-Melittin Hybrids. Significant Size Reduction
Retains Potent Antibiotic Activity. FEBS Lett. 296, 190–194. doi: 10.1016/0014-
5793(92)80377-s
Badosa, E., Ferre, R., Planas, M., Feliu, L., Besalu, E., Cabrefiga, J., et al. (2007). A Library
of Linear Undecapeptides With Bactericidal Activity Against Phytopathogenic
Bacteria. Peptides 28, 2276–2285. doi: 10.1016/j.peptides.2007.09.010
Bechinger, B., and Salnikov, E. S. (2012). The Membrane Interactions of
Antimicrobial Peptides Revealed by Solid-State NMR Spectroscopy. Chem.
Phys. Lipids 165, 282–301. doi: 10.1016/j.chemphyslip.2012.01.009
Binder, H., and Lindblom, G. (2003). Charge-Dependent Translocation of the
Trojan Peptide Penetratin Across Lipid Membranes. Biophys. J. 85, 982–995.
doi: 10.1016/S0006-3495(03)74537-8
Blazyk, J., Wiegand, R., Klein, J., Hammer, J., Epand, R. M., Epand, R. F., et al.
(2001). A Novel Linear Amphipathic b-Sheet Cationic Antimicrobial Peptide
With Enhanced Selectivity for Bacterial Lipids. J. Biol. Chem. 276, 27899–
27906. doi: 10.1074/jbc.M102865200
Blumenthal, R., Clague, M. J., Durell, S. R., and Epand, R. M. (2003). Membrane
Fusion. Chem. Rev. 103, 53–69. doi: 10.1021/cr000036+
Boman, H. G. (1991). Antibacterial Peptides: Key Components Needed in
Immunity. Cell 65, 205–207. doi: 10.1016/0092-8674(91)90154-q
Boman, H. G. (2003). Antibacterial Peptides: Basic Facts and Emerging Concepts.
J. Int. Med. 254, 197–215. doi: 10.1046/j.1365-2796.2003.01228.x
Brogden, K. A. (2005). Antimicrobial Peptides: Pore Formers or Metabolic
Inhibitors in Bacteria? Nat. Rev. Microbiol. 3, 238–250. doi: 10.1038/
nrmicro1098
Bürck, J., Roth, S., Wadhwani, P., Afonin, S., Kanithasen, N., Strandberg, E., et al.
(2008). Conformation and Membrane Orientation of Amphiphilic Helical
Peptides by Oriented Circular Dichroism. Biophys. J. 95, 3872–3881.
doi: 10.1529/biophysj.108.136085
Cavallarin, L., Andreu, D., and San Segundo, B. (1998). Cecropin A-Derived
Peptides are Potent Inhibitors of Fungal Plant Pathogens. Mol. Plant-Microbe
Interact. 11, 218–227. doi: 10.1094/MPMI.1998.11.3.218
Derossi, D., Calvet, S., Trembleau, A., Brunissen, A., Chassaing, G., and
Prochiantz, A. (1996). Cell Internalization of the Third Helix of the
Antennapedia Homeodomain is Receptor-Independent. J. Biol. Chem. 271,
18188–18193. doi: 10.1074/jbc.271.30.18188
Eggenberger, K., Mink, C., Wadhwani, P., Ulrich, A. S., and Nick, P. (2011). Using
the Peptide BP100 as a Cell-Penetrating Tool for the Chemical Engineering of
Actin Filaments Within Living Plant Cells. ChemBioChem 12, 132–137.
doi: 10.1002/cbic.201000402
Eggenberger, K., Sanyal, P., Hundt, S., Wadhwani, P., Ulrich, A. S., and Nick, P.
(2017). Challenge Integrity: The Cell-Penetrating Peptide BP100 Interferes
With the Auxin-Actin Oscillator. Plant Cell Physiol. 58, 71–85. doi: 10.1093/
pcp/pcw161
Eiriksdottir, E., Konate, K., Langel, U., Divita, G., and Deshayes, S. (2010). Secondary
Structure of Cell-Penetrating Peptides ControlsMembrane Interaction and Insertion.
Biochim. Biophys. Acta 1798, 1119–1128. doi: 10.1016/j.bbamem.2010.03.005
Fernandez, D. I., Gehman, J. D., and Separovic, F. (2009). Membrane Interactions
of Antimicrobial Peptides From Australian Frogs. Biochim. Biophys. Acta 1788,
1630–1638. doi: 10.1016/j.bbamem.2008.10.007Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 12Ferre, R., Badosa, E., Feliu, L., Planas, M., Montesinos, E., and Bardaji, E. (2006).
Inhibition of Plant-Pathogenic Bacteria by Short Synthetic Cecropin A-Melittin
Hybrid Peptides. Appl. Environ. Microbiol. 72, 3302–3308. doi: 10.1128/
AEM.72.5.3302-3308.2006
Ferre, R., Melo, M. N., Correia, A. D., Feliu, L., Bardaji, E., Planas, M., et al. (2009).
Synergistic Effects of the Membrane Actions of Cecropin-Melittin
Antimicrobial Hybrid Peptide BP100. Biophys. J. 96, 1815–1827.
doi: 10.1016/j.bpj.2008.11.053
Fields, G. B., and Noble, R. L. (1990). Solid-Phase Peptide Synthesis Utilizing 9-
Fluorenylmethoxycarbonyl Amino Acids. Int. J. Pept. Protein Res. 35, 161–214.
doi: 10.1111/j.1399-3011.1990.tb00939.x
Freed, E. O., Myers, D. J., and Risser, R. (1990). Characterization of the Fusion
Domain of the Human Immunodeficiency Virus Type 1 Envelope
Glycoprotein Gp41. Proc. Natl. Acad. Sci. U.S.A. 87, 4650–4654.
doi: 10.1073/pnas.87.12.4650
Frigyes, D., Alber, F., Pongor, S., and Carloni, P. (2001). Arginine-Phosphate Salt
Bridges in Protein-DNA Complexes: A Car-Parrinello Study. J. Mol. Struc-
Theochem. 574, 39–45. doi: 10.1016/S0166-1280(01)00368-2
Futaki, S., Suzuki, T., Ohashi, W., Yagami, T., Tanaka, S., Ueda, K., et al. (2001).
Arginine-Rich Peptides: An Abundant Source of Membrane-Permeable
Peptides Having Potential as Carriers for Intracellular Protein Delivery.
J. Biol. Chem. 276, 5836–5840. doi: 10.1074/jbc.M007540200
Gagnon, M. C., Strandberg, E., Grau-Campistany, A., Wadhwani, P., Reichert, J.,
Bürck, J., et al. (2017). Influence of the Length and Charge on the Activity of a-
Helical Amphipathic Antimicrobial Peptides. Biochemistry 56, 1680–1695.
doi: 10.1021/acs.biochem.6b01071
Gao, N. N., Wadhwani, P., Mühlhaüser, P., Liu, Q., Riemann, M., Ulrich, A. S.,
et al. (2016). An Antifungal Protein From Ginkgo Biloba Binds Actin and Can
Trigger Cell Death. Protoplasma 253, 1159–1174. doi: 10.1007/s00709-015-
0876-4
Glaser, R. W., Sachse, C., Dürr, U. H. N., Afonin, S., Wadhwani, P., Strandberg, E.,
et al. (2005). Concentration-Dependent Realignment of the Antimicrobial
Peptide PGLa in Lipid Membranes Observed by Solid-State 19F-NMR. Biophys.
J. 88, 3392–3397. doi: 10.1529/biophysj.104.056424
Glaser, R. W., Sachse, C., Dürr, U. H. N., Wadhwani, P., and Ulrich, A. S. (2004).
Orientation of the Antimicrobial Peptide PGLa in Lipid Membranes
Determined From 19F-NMR Dipolar Couplings of 4-CF3-Phenylglycine
Labels. J. Magn. Reson. 168, 153–163. doi: 10.1016/j.jmr.2004.02.008
Grau-Campistany, A., Strandberg, E., Wadhwani, P., Rabanal, F., and Ulrich, A. S.
(2016). Extending the Hydrophobic Mismatch Concept to Amphiphilic
Membranolytic Peptides. J. Phys. Chem. Lett. 7, 1116–1120. doi: 10.1021/
acs.jpclett.6b00136
Grau-Campistany, A., Strandberg, E., Wadhwani, P., Reichert, J., Bürck, J.,
Rabanal, F., et al. (2015). Hydrophobic Mismatch Demonstrated for
Membranolytic Peptides, and Their Use as Molecular Rulers to Measure
Bilayer Thickness in Native Cells. Sci. Rep. 5, 9388. doi: 10.1038/srep09388
Henriques, S. T., Melo, M. N., and Castanho, M. A. (2006). Cell-Penetrating
Peptides and Antimicrobial Peptides: How Different are They? Biochem. J. 399,
1–7. doi: 10.1042/BJ20061100
Huang, H. W. (2006). Molecular Mechanism of Antimicrobial Peptides: The
Origin of Cooperativity. Biochim. Biophys. Acta 1758, 1292–1302. doi: 10.1016/
j.bbamem.2006.02.001
Kucerka, N., Tristram-Nagle, S., and Nagle, J. F. (2006). Structure of Fully
Hydrated Fluid Phase Lipid Bilayers With Monounsaturated Chains.
J. Membr. Biol. 208, 193–202. doi: 10.1007/s00232-005-7006-8
Langel, Ü (2002). Cell-Penetrating Peptides: Processes and Applications (Boca
Raton, FL: CRC Press).
Ludtke, S. J., He, K., Heller, W. T., Harroun, T. A., Yang, L., and Huang, H. W.
(1996). Membrane Pores Induced by Magainin. Biochemistry 35, 13723–13728.
doi: 10.1021/bi9620621
Ludtke, S. J., He, K., Wu, Y. L., and Huang, H. W. (1994). Cooperative Membrane
Insertion of Magainin CorrelatedWith Its Cytolytic Activity. Biochim. Biophys.
Acta 1190, 181–184. doi: 10.1016/0005-2736(94)90050-7
Maloy, W. L., and Kari, U. P. (1995). Structure-Activity Studies on Magainins and
Other Host-Defense Peptides. Biopolymers 37, 105–122. doi: 10.1002/
bip.360370206
Marsh, D. (2008). Energetics of Hydrophobic Matching in Lipid-Protein
Interactions. Biophys. J. 94, 3996–4013. doi: 10.1529/biophysj.107.121475April 2021 | Volume 11 | Article 609542
Mink et al. Short Multifunctional Peptide BP100Mathew, M. K., and Balaram, P. (1983). A Helix Dipole Model for Alamethicin
and Related Transmembrane Channels. FEBS Lett. 157, 1–5. doi: 10.1016/
0014-5793(83)81105-3
Matsuzaki, K. (1998). Magainins as Paradigm for the Mode of Action of Pore
Forming Polypeptides. Biochim. Biophys. Acta 1376, 391–400. doi: 10.1016/
s0304-4157(98)00014-8
Matsuzaki, K., Mitani, Y., Akada, K. Y., Murase, O., Yoneyama, S., Zasloff, M.,
et al. (1998). Mechanism of Synergism Between Antimicrobial Peptides
Magainin 2 and PGLa. Biochemistry 37, 15144–15153. doi: 10.1021/bi9811617
Matsuzaki, K., Murase, O., and Miyajima, K. (1995). Kinetics of Pore Formation
by an Antimicrobial Peptide, Magainin 2, in Phospholipid Bilayers.
Biochemistry 34, 12553–12559. doi: 10.1021/bi00039a009
Melo, M. N., Ferre, R., and Castanho, M. A. R. B. (2009). Antimicrobial Peptides:
Linking Partition, Activity and High Membrane-Bound Concentrations. Nat.
Rev. Microbiol. 7, 245–250. doi: 10.1038/nrmicro2095
Misiewicz, J., Afonin, S., Grage, S. L., van den Berg, J., Strandberg, E., Wadhwani, P.,
et al. (2015). Action of the Multifunctional Peptide BP100 on Native
Biomembranes Examined by Solid-State NMR. J. Biomol. NMR 61, 287–298.
doi: 10.1007/s10858-015-9897-8
Nekhotiaeva, N., Elmquist, A., Rajarao, G. K., Hällbrink, M., Langel, Ü, and Good,
L. (2004). Cell Entry and Antimicrobial Properties of Eukaryotic Cell-
Penetrating Peptides. FASEB J. 18, 394–396. doi: 10.1096/fj.03-0449fje
Oehlke, J., Scheller, A., Wiesner, B., Krause, E., Beyermann, M., Klauschenz, E.,
et al. (1998). Cellular Uptake of an a-Helical Amphipathic Model PeptideWith
the Potential to Deliver Polar Compounds Into the Cell Interior Non-
Endocytically. Biochim. Biophys. Acta 1414, 127–139. doi: 10.1016/s0005-
2736(98)00161-8
Oren, Z., and Shai, Y. (1998). Mode of Action of Linear Amphipathic a-Helical
Antimicrobial Peptides. Biopolymers 47, 451–463. doi: 10.1002/(SICI)1097-
0282(1998)47:6<451::AID-BIP4>3.0.CO;2-F
Pan, J., Heberle, F. A., Tristram-Nagle, S., Szymanski, M., Koepfinger, M., Katsaras, J.,
et al. (2012). Molecular Structures of Fluid Phase Phosphatidylglycerol Bilayers as
Determined by Small Angle Neutron and X-Ray Scattering. Biochim. Biophys. Acta
1818, 2135–2148. doi: 10.1016/j.bbamem.2012.05.007
Papo, N., and Shai, Y. (2003). Can We Predict Biological Activity of Antimicrobial
Peptides From Their Interactions With Model Phospholipid Membranes?
Peptides 24, 1693–1703. doi: 10.1016/j.peptides.2003.09.013
Peschel, A., and Sahl, H. G. (2006). The Co-Evolution of Host Cationic
Antimicrobial Peptides and Microbial Resistance. Nat. Rev. Microbiol. 4,
529–536. doi: 10.1038/nrmicro1441
Pettersen, E. F., Goddard, T. D., Huang, C. C., Couch, G. S., Greenblatt, D. M.,
Meng, E. C., et al. (2004). UCSF Chimera: A Visualization System for
Exploratory Research and Analysis. J. Comp. Chem. 25, 1605–1612.
doi: 10.1002/Jcc.20084
Pouny, Y., Rapaport, D., Mor, A., Nicolas, P., and Shai, Y. (1992). Interaction of
Antimicrobial Dermaseptin and Its Fluorescently Labeled Analogs With
Phospholipid Membranes. Biochemistry 31, 12416–12423. doi: 10.1021/
bi00164a017
Reißer, S., Strandberg, E., Steinbrecher, T., and Ulrich, A. S. (2014). 3D
Hydrophobic Moment Vectors as a Tool to Characterize the Surface Polarity
of Amphiphilic Peptides. Biophys. J. 106, 2385–2394. doi: 10.1016/
j.bpj.2014.04.020
Reichert, J., Grasnick, D., Afonin, S., Bürck, J., Wadhwani, P., and Ulrich, A. S.
(2007). A Critical Evaluation of the Conformational Requirements of
Fusogenic Peptides in Membranes. Eur. Biophys. J. 36, 405–413.
doi: 10.1007/s00249-006-0106-2
Sabatier, J. M., Vives, E., Mabrouk, K., Benjouad, A., Rochat, H., Duval, A., et al.
(1991). Evidence for Neurotoxic Activity of Tat From Human
Immunodeficiency Virus Type 1. J. Virol. 65, 961–967. doi: 10.1128/JVI.65.
2.961-967.1991
Sakai, N., and Matile, S. (2003). Anion-Mediated Transfer of Polyarginine Across
Liquid and Bilayer Membranes. J. Am. Chem. Soc 125, 14348–14356.
doi: 10.1021/Ja0376011
Soravia, E., Martini, G., and Zasloff, M. (1988). Antimicrobial Properties of
Peptides From Xenopus Granular Gland Secretions. FEBS Lett. 228, 337–340.
doi: 10.1016/0014-5793(88)80027-9
Steiner, V., Schär, M., Börnsen, K. O., and Mutter, M. (1991). Retention Behaviour
of a Template-Assembled Synthetic Protein and Its Amphiphilic BuildingFrontiers in Cellular and Infection Microbiology | www.frontiersin.org 13Blocks on Reversed-Phase Columns. J. Chromatogr. 586, 43–50. doi: 10.1016/
0021-9673(91)80023-a
Strandberg, E., Bentz, D., Wadhwani, P., Bürck, J., and Ulrich, A. S. (2020a).
Terminal Charges Modulate the Pore Forming Activity of Cationic
Amphipathic Helices. BBA-Biomembranes 1862, 183243. doi: 10.1016/
j.bbamem.2020.183243
Strandberg, E., Bentz, D., Wadhwani, P., and Ulrich, A. S. (2020b). Chiral
Supramolecular Architecture of Stable Transmembrane Pores Formed by an
a-Helical Antibiotic Peptide in the Presence of Lyso-Lipids. Sci. Rep. 10, 4710.
doi: 10.1038/s41598-020-61526-w
Strandberg, E., Horn, D., Reißer, S., Zerweck, J., Wadhwani, P., and Ulrich, A. S.
(2016). 2H-NMR and MD Simulations Reveal Membrane-Bound
Conformation of Magainin 2 and Its Synergy With PGLa. Biophys. J. 111,
2149–2161. doi: 10.1016/j.bpj.2016.10.012
Strandberg, E., Kanithasen, N., Bürck, J., Wadhwani, P., Tiltak, D., Zwernemann, O.,
et al. (2008). Solid State NMR Analysis Comparing the Designer-Made
Antibiotic MSI-103 With Its Parent Peptide PGLa in Lipid Bilayers.
Biochemistry 47, 2601–2616. doi: 10.1021/bi701944r
Strandberg, E., Tiltak, D., Ehni, S., Wadhwani, P., and Ulrich, A. S. (2012). Lipid Shape
is a Key Factor for Membrane Interactions of Amphipathic Helical Peptides.
Biochim. Biophys. Acta 1818, 1764–1776. doi: 10.1016/j.bbamem.2012.02.027
Strandberg, E., Tiltak, D., Ieronimo, M., Kanithasen, N., Wadhwani, P., and
Ulrich, A. S. (2007). Influence of C-Terminal Amidation on the Antimicrobial
and Hemolytic Activities of Cationic a-Helical Peptides. Pure Appl. Chem. 79,
717–728. doi: 10.1351/pac200779040717
Strandberg, E., Wadhwani, P., Tremouilhac, P., Dürr, U. H. N., and Ulrich, A. S.
(2006). Solid-State NMR Analysis of the PGLa Peptide Orientation in DMPC
Bilayers: Structural Fidelity of 2H-Labels Versus High Sensitivity of 19F-NMR.
Biophys. J. 90, 1676–1686. doi: 10.1529/biophysj.105.073858
Strandberg, E., Zerweck, J., Wadhwani, P., and Ulrich, A. S. (2013). Synergistic
Insertion of Antimicrobial Magainin-Family Peptides in Membranes Depends
on the Lipid Spontaneous Curvature. Biophys. J. 104, L9–11. doi: 10.1016/
j.bpj.2013.01.047
Takeshima, K., Chikushi, A., Lee, K. K., Yonehara, S., and Matsuzaki, K. (2003).
Translocation of Analogues of the Antimicrobial Peptides Magainin and
Buforin Across Human Cell Membranes. J. Biol. Chem. 278, 1310–1315.
doi: 10.1074/jbc.M208762200
Terrone, D., Sang, S. L. W., Roudaia, L., and Silvius, J. R. (2003). Penetratin and
Related Cell-Penetrating Cationic Peptides Can Translocate Across Lipid
Bilayers in the Presence of a Transbilayer Potential. Biochemistry 42, 13787–
13799. doi: 10.1021/bi035293y
Thorén, P. E., Persson, D., Isakson, P., Goksör, M., Önfelt, A., and Nordén, B.
(2003). Uptake of Analogs of Penetratin, Tat(48-60) and Oligoarginine in Live
Cells. Biochem. Biophys. Res. Commun. 307, 100–107. doi: 10.1016/S0006-291X
(03)01135-5
Thorén, P. E., Persson, D., Lincoln, P., and Nordén, B. (2005). Membrane
Destabilizing Properties of Cell-Penetrating Peptides. Biophys. Chem. 114,
169–179. doi: 10.1016/j.bpc.2004.11.016
Tremouilhac, P., Strandberg, E., Wadhwani, P., and Ulrich, A. S. (2006).
Conditions Affecting the Re-Alignment of the Antimicrobial Peptide PGLa
in Membranes as Monitored by Solid State 2H-NMR. Biochim. Biophys. Acta
1758, 1330–1342. doi: 10.1016/j.bbamem.2006.02.029
Vives, E., Brodin, P., and Lebleu, B. (1997). A Truncated HIV-1 Tat Protein Basic
Domain Rapidly Translocates Through the Plasma Membrane and
Accumulates in the Cell Nucleus. J. Biol. Chem. 272, 16010–16017.
doi: 10.1074/jbc.272.25.16010
Wadhwani, P., Bürck, J., Strandberg, E., Mink, C., Afonin, S., and Ulrich, A. S.
(2008). Using a Sterically Restrictive Amino Acid as a 19F-NMR Label to
Monitor and Control Peptide Aggregation in Membranes. J. Am. Chem. Soc
130, 16515–16517. doi: 10.1021/ja804928q
Wadhwani, P., Epand, R. F., Heidenreich, N., Bürck, J., Ulrich, A. S., and Epand,
R. M. (2012a). Membrane-Active Peptides and the Clustering of Anionic
Lipids. Biophys. J. 103, 265–274. doi: 10.1016/j.bpj.2012.06.004
Wadhwani, P., Reichert, J., Bürck, J., and Ulrich, A. S. (2012b). Antimicrobial and
Cell Penetrating Peptides Induce Lipid Vesicle Fusion by Folding and
Aggregation. Eur. Biophys. J. 41, 177–187. doi: 10.1007/s00249-011-0771-7
Wadhwani, P., Strandberg, E., van den Berg, J., Mink, C., Bürck, J., Ciriello, R.,
et al. (2014). Dynamical Structure of the Short Multifunctional Peptide BP100April 2021 | Volume 11 | Article 609542
Mink et al. Short Multifunctional Peptide BP100in Membranes. Biochim. Biophys. Acta 1838, 940–949. doi: 10.1016/
j.bbamem.2013.11.001
Wang, H., Zhong, C. Y., Wu, J. F., Huang, Y. B., and Liu, C. B. (2010).
Enhancement of TAT Cell Membrane Penetration Efficiency by Dimethyl
Sulphoxide. J. Control Release. 143, 64–70. doi: 10.1016/j.jconrel.2009.12.003
White, J. M., Delos, S. E., Brecher, M., and Schornberg, K. (2008). Structures and
Mechanisms of Viral Membrane Fusion Proteins: Multiple Variations on a
Common Theme. Crit. Rev. Biochem. Mol. Biol. 43, 189–219. doi: 10.1080/
10409230802058320
Yang, R., Yang, J., and Weliky, D. P. (2003). Synthesis, Enhanced Fusogenicity,
and Solid State NMR Measurements of Cross-Linked HIV-1 Fusion Peptides.
Biochemistry 42, 3527–3535. doi: 10.1021/bi027052g
Zamora-Carreras, H., Strandberg, E., Mühlhäuser, P., Bürck, J., Wadhwani, P., Jiménez,
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